Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Conditions: Uterine Cervical Neoplasms; Chemoradiotherapy; Angiogenesis Interventions: Drug: Hydrochloride anlotinib; Drug: cis Platinum/carboplatin; Radiation: External beam radiotherapy and brachytherapy Sponsor: Zhongnan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | External Beam Therapy | Hospitals | Research